VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
enoxaparin/tinzaparin/dalteparin
Phase 3
Small molecule
H
Helsinki University Central Hospital
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Pancreatic Surgery
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Pancreatic Surgery
Phase 3
Recruiting
Clinical
Trials by Indication
[1]
Pancreatic Surgery
1 trial
Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
Recruiting
·
H
Helsinki University Central Hospital
·
Phase 4
·
NCT05245877
·
800 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for enoxaparin/tinzaparin/dalteparin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
enoxaparin/tinzaparin/dalteparin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for enoxaparin/tinzaparin/dalteparin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Helsinki University Central Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 3
[1]
Company
H
Helsinki University Central Hospital
Related News